Opioid manufacturer Insys Therapeutics agrees to pay a $225 million settlement to resolve federal government's criminal and civil investigations into the company's illegal marketing of a powerful but highly-addictive painkiller, prosecutors say.
Opioid manufacturer Insys Therapeutics has agreed to pay a $225 million settlement to resolve the federal government's criminal and civil investigations into the company's illegal marketing of a powerful but highly-addictive painkiller, prosecutors said Wednesday.
Insys Therapeutics officials said the deferred prosecution agreement with the government is"in the best interest of the company and its stakeholders." Prosecutors said that Insys Therapeutics used sham"speaker programs" from August 2012 to June 2015 to pay bribes and kickbacks to doctors and nurse practitioners in exchange for writing prescriptions for Subsys, a fentanyl-based medication that's sprayed under the tongue, and for increasing the dosage of those prescriptions.
“For years, Insys engaged in prolonged, illegal conduct that prioritized its profits over the health of the thousands of patients who relied on it," Andrew E. Lelling, the United States attorney for the District of Massachusetts, said in a statement Wednesday."Today, the company is being held responsible for that and for its role in fueling the opioid epidemic.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Opioid maker agrees to pay $225M to settle federal probesAn opioid manufacturer has agreed to pay $225 million to resolve federal investigations into allegations that it paid kickbacks and used other illegal marketing tactics to sell a powerful fentanyl spray, authorities said Wednesday. The settlement stems from criminal and civil probes into Insys Therapeutics
Read more »
Opioid manufacturer agrees to pay $225 million to settle corruption caseAn opioid manufacturer has agreed to pay $225 million to resolve federal investigations into allegations that it paid kickbacks and used other illegal marketing tactics to sell fentanyl spray
Read more »
Opioid maker agrees to pay $225M to settle federal probesAn opioid manufacturer has agreed to pay $225 million to resolve federal investigations into allegations that it paid kickbacks and used other illegal marketing tactics to sell a powerful fentanyl spray, authorities said Wednesday. The settlement stems from criminal and civil probes into Insys Therapeutics
Read more »